Compounding Pharmacy Recalls GLP-1 Injections Due to Sterility Concerns

Apothecary Pharma, a compounding pharmacy, has issued a voluntary recall of 22 lots of its compounded tirzepatide, a copycat version of Eli Lilly's obesity drug Zepbound. The recall is due to a lack of assurance regarding the medication's safety and sterility, and has been classified as Class II by the FDA.